AMGEN ANNOUNCES TOPLINE DATA FROM LUMAKRAS® (SOTORASIB) PHASE 3 TRIAL IN NON-SMALL CELL LUNG CANCER

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. SPG

Go back to AMGEN ANNOUNCES TOPLINE DATA FROM LUMAKRAS® (SOTORASIB) PHASE 3 TRIAL IN NON-SMALL CELL LUNG CANCER
Amgen Inc (NASDAQ: AMGN) Delayed: 437.23 -6.89 (1.55%)
Previous Close $444.12    52 Week High $176.85 
Open $437.03    52 Week Low $133.64 
Day High $441.85    P/E 65.85 
Day Low $435.00    EPS $6.64 
Volume 1,656,089